Clinical trial
MEND 2: Making Treatment Decisions Using Genomic Testing
NCT03183050 is registered in ClinicalTrials.gov with Georgetown University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MEND 2: Making Treatment Decisions Using Genomic Testing
- Lead sponsor
- Georgetown University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 2, 2017
- Completion date
- January 14, 2019
- Enrollment
- 88 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer female